IMCC
Price
$0.16
Change
-$0.02 (-11.11%)
Updated
Jun 23, 04:59 PM (EDT)
Capitalization
1.56M
Intraday BUY SELL Signals
TRLV
Price
$8.51
Change
-$0.61 (-6.69%)
Updated
Jun 23, 04:18 PM (EDT)
Capitalization
1.75B
50 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

IMCC vs TRLV

IMCC vs TRLV Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
IMCC vs. TRLV commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMCC is a Hold and TRLV is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 24, 2026
Stock price -- (IMCC: $0.17 vs. TRLV: $9.12)
Brand notoriety: IMCC and TRLV are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: IMCC: 32% vs. TRLV: 191%
Market capitalization -- IMCC: $1.56M vs. TRLV: $1.75B
IMCC [@Pharmaceuticals: Generic] is valued at $1.56M. TRLV’s [@Pharmaceuticals: Generic] market capitalization is $1.75B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMCC’s FA Score shows that 1 FA rating(s) are green whileTRLV’s FA Score has 1 green FA rating(s).

  • IMCC’s FA Score: 1 green, 4 red.
  • TRLV’s FA Score: 1 green, 4 red.
According to our system of comparison, TRLV is a better buy in the long-term than IMCC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMCC’s TA Score shows that 4 TA indicator(s) are bullish while TRLV’s TA Score has 4 bullish TA indicator(s).

  • IMCC’s TA Score: 4 bullish, 4 bearish.
  • TRLV’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, IMCC is a better buy in the short-term than TRLV.

Price Growth

IMCC (@Pharmaceuticals: Generic) experienced а -33.91% price change this week, while TRLV (@Pharmaceuticals: Generic) price change was -7.51% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -0.70%. For the same industry, the average monthly price growth was +0.08%, and the average quarterly price growth was +8.31%.

Reported Earning Dates

TRLV is expected to report earnings on Aug 12, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-0.70% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TRLV($1.75B) has a higher market cap than IMCC($1.56M). TRLV YTD gains are higher at: 4.948 vs. IMCC (-87.590).
IMCCTRLVIMCC / TRLV
Capitalization1.56M1.75B0%
EBITDA-8.75MN/A-
Gain YTD-87.5904.948-1,770%
P/E RatioN/AN/A-
Revenue50.9MN/A-
Total Cash1MN/A-
Total Debt15MN/A-
FUNDAMENTALS RATINGS
IMCC vs TRLV: Fundamental Ratings
IMCC
TRLV
OUTLOOK RATING
1..100
6475
VALUATION
overvalued / fair valued / undervalued
1..100
28
Undervalued
81
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9894
PRICE GROWTH RATING
1..100
9536
P/E GROWTH RATING
1..100
10021
SEASONALITY SCORE
1..100
5048

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IMCC's Valuation (28) in the null industry is somewhat better than the same rating for TRLV (81). This means that IMCC’s stock grew somewhat faster than TRLV’s over the last 12 months.

IMCC's Profit vs Risk Rating (100) in the null industry is in the same range as TRLV (100). This means that IMCC’s stock grew similarly to TRLV’s over the last 12 months.

TRLV's SMR Rating (94) in the null industry is in the same range as IMCC (98). This means that TRLV’s stock grew similarly to IMCC’s over the last 12 months.

TRLV's Price Growth Rating (36) in the null industry is somewhat better than the same rating for IMCC (95). This means that TRLV’s stock grew somewhat faster than IMCC’s over the last 12 months.

TRLV's P/E Growth Rating (21) in the null industry is significantly better than the same rating for IMCC (100). This means that TRLV’s stock grew significantly faster than IMCC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IMCCTRLV
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
80%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 29 days ago
83%
Bullish Trend 6 days ago
76%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 8 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
84%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
IMCC
Daily Signal:
Gain/Loss:
TRLV
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
LTCC10.880.26
+2.46%
Canary Litecoin ETF
XSLV50.710.19
+0.37%
Invesco S&P SmallCap Low Volatility ETF
FSEP55.00-0.05
-0.09%
FT Vest US Equity Buffer ETF Sep
RFLR31.63-0.07
-0.22%
Innovator U.S. Small Cp Mgd Flr ETF
RETL8.47-0.21
-2.42%
Direxion Daily Retail Bull 3X ETF

TRLV and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRLV has been closely correlated with CGC. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if TRLV jumps, then CGC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRLV
1D Price
Change %
TRLV100%
-9.70%
CGC - TRLV
67%
Closely correlated
-0.85%
CRON - TRLV
60%
Loosely correlated
-2.21%
ACB - TRLV
60%
Loosely correlated
-2.05%
OGI - TRLV
54%
Loosely correlated
+0.34%
YCBD - TRLV
50%
Loosely correlated
-4.15%
More